Negative operating cash flow ….$0.9m v positive $3.5m pcp
Percy …what’s up
This was caused by COVID-19 related travel and
freight restrictions, along with a four-month shut down of the
Company’s largest freeze dryer to install an additional dryer
without overseas engineering support
We are
seeing potential for some of the strongest demand in our
history and decisions to progress with expansion plans during
the pandemic mean we are well positioned to take advantage
of increased opportunities.
Product being rebranded.[I think]
ie PAZ are about to relaunch their online offering,which [again I think] will include a number of new products.
Possibly we will hear more at the agm,which I trust the bowlers will be attending or watching.
We also have a number of other well researched and considered new product
development opportunities that the Board is very excited by. These opportunities,
coupled with continuing strong demand for our existing products, an easing of
border restrictions and our newly developed engineering capabilities, position
PharmaZen for substantially better growth in 2022.
($813,600) Loss after tax, Ouch ! Just as well according to some, earnings don't matter and its all about the future.
Ecclesiastes 11:2: Divide your portion to seven, or even to eight, for you do not know what misfortune may occur on the earth.
Ben Graham - In the short run the market is a voting machine but in the long run the market is a weighing machine
Originally Posted by percy
Reply With Quote
Bookmarks